search
Get Started
search
Randy Schekman - Physician
zoom_in Click to enlarge

Randy Schekman

description Randy Schekman Overview

Randy Schekman is an American cell biologist and professor at the University of California, Berkeley, where he has spent most of his academic career. He shared the 2013 Nobel Prize in Physiology or Medicine with James Rothman and Thomas Südhof for identifying the genetic basis of vesicle trafficking in yeast, a membrane-transport process conserved across eukaryotes from yeast to humans. His research used yeast genetics to reveal genes that control secretion and intracellular transport. Schekman also served as editor-in-chief of the open-access journal eLife and previously edited Proceedings of the National Academy of Sciences.

insights Ranking position

Randy Schekman ranks #59 of 150 in the Physician ranking, behind Alfred Blalock, ahead of William Crawford Gorgas.

help Randy Schekman FAQ

What did Randy Schekman discover about vesicle transport using yeast genetics?

Schekman used baker's yeast (Saccharomyces cerevisiae) to identify a class of genes, called SEC genes, that are required for vesicles to form inside the cell and to transport proteins to their correct destinations. By studying yeast mutants that accumulated vesicles in the wrong places, he established the genetic blueprint for the cell's secretory transport system.

Who did Randy Schekman share the 2013 Nobel Prize with?

Schekman shared the 2013 Nobel Prize in Physiology or Medicine with James Rothman of Yale University and Thomas Südhof of Stanford University. Schekman was recognized for the genetic basis of vesicle transport, Rothman for the protein machinery (SNARE proteins) that fuses vesicles with target membranes, and Südhof for the calcium-triggered mechanisms that control neurotransmitter release at synapses.

Where does Randy Schekman work and what editorial roles has he held?

Schekman is a professor of molecular and cell biology at the University of California, Berkeley, where he has spent most of his career. He also served as editor-in-chief of the journal eLife and was previously editor-in-chief of the Proceedings of the National Academy of Sciences (PNAS), making him a prominent advocate for open-access scientific publishing.

Why did Schekman use yeast instead of human cells to study vesicle transport?

Yeast offered two key advantages: the ability to easily generate and screen thousands of mutants, and a well-understood genetics system that made it possible to pinpoint which genes were essential for each step of transport. Many of the SEC genes Schekman identified in yeast have direct counterparts in human cells, showing that the vesicle transport machinery is evolutionarily conserved.

Reviews & Comments

Write a Review

rate_review

Be the first to review

Share your thoughts with the community and help others make better decisions.

Save to your list

Save your favorites and follow how their scores change over time.

Save favorites
Get updates
Compare scores

Already have an account? Sign in

Compare Items

See how they stack up against each other

Comparing
VS
Select 1 more item to compare